What does impairment of strategic investments mean?

Captures the non-cash charges recognized when the carrying value of strategic equity investments exceeds their fair value due to a decline in the investee's financial health. This metric signals potential risks associated with the company's investment portfolio and long-term asset valuation.

VirnetX Holding Corp VHC Impairment of strategic investments

Impairment of strategic investments at other companies

NuSkin EnterprisesNUS

$0-100%

VirnetX Holding Corp VHC

$500K—

Clean Energy FuelsCLNE

$0-100%

QuinStreetQNST

$0-100%

Veeco InstrumentsVECO

$101K—

LivaNovaLIVN

$1.13M—

Other financials

Income statement

See full

Revenue-—

Operating income-$4.5M-11.4%

Net income-$4.4M-18.3%

EPS (diluted)-$1.16-14.9%

Balance sheet

See full

Cash & equivalents$14.8M-36.4%

Total debt$7.2M-10.8%

Total equity$18.9M-48.2%

Total assets$26.7M-40.8%

Cash flow

See full

Operating cash flow-$4.3M-10.3%

CapEx$17.0K—

Free cash flow-$5.8M-5.2%

Valuation

See full

Market cap$53.16M+26.6%

Enterprise value$45.6M+39.7%

P/S328.2×-512×

Profitability

See full

Operating margin-12,284.6%-6,084pp

Net margin-11,666.7%-5,775pp

FCF margin-35,193.8%—

Returns & leverage

See full

Return on equity-68.5%+181pp

Debt / equity0.4×+0.2×

Current ratio8.5×-9.2×

Where this comes from

Reported directly by VirnetX Holding Corp in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount.

The official record: VirnetX Holding Corp ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about VirnetX Holding Corp 's impairment of strategic investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is VirnetX Holding Corp 's impairment of strategic investments?: VirnetX Holding Corp (VHC) reported impairment of strategic investments of $500K in Q1 2026.
What does impairment of strategic investments mean?: Captures the non-cash charges recognized when the carrying value of strategic equity investments exceeds their fair value due to a decline in the investee's financial health. This metric signals potential risks associated with the company's investment portfolio and long-term asset valuation.